Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris largest European hotel group (EPA: AC) at €5.6B+ 2024 revenue with 5,700+ hotels in 110 countries; LVMH Orient Express partnership and 45 brands (ibis to Raffles/Fairmont) competing with Marriott and IHG for global hotel franchise.
Accor S.A. is a Paris, France-headquartered global hospitality company — listed on Euronext Paris (EPA: AC) — operating as the largest hotel group in Europe and the sixth-largest globally, with 5,700+ hotels across 110+ countries and 850,000+ rooms under 45 brands spanning budget (ibis, Ibis Styles, Ibis Budget), midscale (Novotel, Mercure, TRIBE), upscale (Pullman, Swissôtel, Mövenpick), and luxury and lifestyle (Fairmont, Raffles, Sofitel, Orient Express, The Hoxton, Mondrian, SLS) segments managed through the Ennismore lifestyle hospitality joint venture. In 2024, Accor generated €5.6+ billion in revenue and €1.1+ billion in recurring EBITDA, opened 293 new hotels (50,000 rooms), and has a development pipeline of 1,315 hotels (225,000 rooms). CEO Sébastien Bazin has led the company since 2013. Key strategic moves include: the 2016 acquisition of Fairmont, Raffles, and Swissôtel for $2.7 billion; the 2024 partnership with LVMH to jointly develop the Orient Express ultra-luxury travel brand; and the formation of Ennismore as the lifestyle hotel vehicle. Founded 1967 by Paul Dubrule and Gérard Pélisson.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.